Your browser doesn't support javascript.
loading
Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3.
Liang, Shi-Fu; Zuo, Fang-Fang; Yin, Bin-Cheng; Ye, Bang-Ce.
  • Liang SF; Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, China. yebangce@zjut.edu.cn.
  • Zuo FF; Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, China. yebangce@zjut.edu.cn.
  • Yin BC; Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, China. yebangce@zjut.edu.cn.
  • Ye BC; Lab of Biosystem and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science & Technology, Shanghai, 200237, China. binchengyin@ecust.edu.cn.
Biomater Sci ; 10(6): 1582-1590, 2022 Mar 15.
Article en En | MEDLINE | ID: mdl-35179533

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glioblastoma / Exosomas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glioblastoma / Exosomas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article